The success of Pfizer's mRNA-based COVID vaccine looks set to secure the company a multi-billion dollar windfall for many years as countries already start booking in for booster shots.
The success of its COVID vaccine, and the challenges faced by some of its rivals, look set to earn US pharmaceutical giant Pfizer at least an extra $US11 billion in revenue this year.The company is hoping to ramp up production to 2.5 billion doses this year and three billion in 2022
Pfizer is evaluating a prototype to include the South African variant and expects annual flu-style vaccinations will be needed for the coronavirus The company now expects to pull in $US26 billion of income from its COVID-19 vaccine this year, based on contracts signed up to mid-April, up from an earlier estimate of $US15 billion.contracting for an extra 20 million doses by the end of the yearPfizer now has contracts in place for 1.6 billion doses of its vaccine to be delivered in 2021, enough to vaccinate 800 million people.
However, the company said it hoped to have manufacturing capacity to produce up to 2.5 billion doses this year and 3 billion in 2022, meaning revenue from the vaccine could grow further still. The increase in capacity is dependant on expanding output at current facilities and signing up other firms to manufacture the vaccine on contract.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer COVID-19 vaccine expiry deadline triggers vaccination blitz in Alice SpringsAn Alice Springs health organisation is given 150 doses of the Pfizer vaccine left over from another vaccination campaign. But they have to be used before they expire at the end of the day.
Read more »
European Union secures a potential 1.8 billion doses of the Pfizer COVID-19 vaccinePresident Ursula von der Leyen says 900 million vaccine doses of the Pfizer vaccine are guaranteed for the bloc, weeks after the EU sued AstraZeneca for not meeting the terms of its contract.
Read more »
Hope for developing nations as US backs global waiver on COVID-19 vaccine patentsUS President Joe Biden's administration on Wednesday announced support for a global waiver on patent protections for COVID-19 vaccines, offering hope to poor nations that have struggled to access the life-saving doses.
Read more »
May be a 'missing link' between Sydney COVID-19 cases and US traveller | Sky News AustraliaNew South Wales Chief Health Officer Dr Kerry Chant said there is a possibility of a missing link between the two locally acquired COVID-19 cases and a US traveller in hotel quarantine who share the same virus strain. \n\n“The sequence from our new cases matched with the overseas case who has travelled from the US and went to the Park Royal at Darling Harbour, the person was tested on day one and was positive and was moved to the SHA, the Sydney Health Accommodation, on the 28th [of May],” she said.\n\nDr Chant said NSW Health was “currently reviewing any CCTV footage to look at how transmission occurred” but said there was no direct link they had found.\n\n“We can’t find any direct link between our case so what we’re concerned about is there another person that is yet unidentified that passed it onto our case.”
Read more »
‘Gamechanger’: US backs COVID vaccines patent waiverHard-hit India and South Africa have led a push at the World Trade Organisation (WTO) for a suspension on patent protections for COVID-19 vaccines and diagnostics.
Read more »